Services

    From Clinical Validation to Market Adoption

    Built on over two decades of navigating the diagnostic commercialization window for global leaders and emerging startups. We design and install the go-to-market strategy, channel infrastructure, and revenue architecture that takes a diagnostic platform from clearance to commercial traction.

    View Our Framework

    Strategy

    Go-to-Market Architecture

    Pricing, channel, and launch sequencing

    Global

    US Market Access

    Regulatory sequencing and channel entry

    Growth

    Commercial Infrastructure

    CRM, ROI models, and field operations

    Precision commercial architecture across molecular diagnostics, point of care testing, and decentralized testing environments.

    Commercial Framework

    Three Pillars of Diagnostic Commercialization

    Every engagement is structured around three interdependent pillars that convert regulatory clearance into repeatable market adoption.

    01

    Evidence Strategy

    Architect go-to-market sequencing, pricing logic, and clinical utility mapping for the 0-to-1 commercialization window.

    Focus Areas

    • Go-to-Market Strategy and launch sequencing
    • Pricing Architecture anchored to workflow economics
    • Clinical Utility Mapping for buyer procurement confidence

    Strategic Deliverables

    Clinical Utility Mapping

    Link analytical claims to physician decision-making criteria and payer coverage triggers.

    Economic Value Narratives

    Build evidence-based ROI models that translate clinical outcomes into procurement language.

    02

    Market Access

    Prioritize regulatory sequencing and reimbursement alignment to compress time from clearance to contracted clinical use.

    Focus Areas

    • Regulatory Sequencing to prevent capital burn before market entry
    • Reimbursement Alignment for sustainable coverage and coding strategy
    • Channel Access Optimization by readiness and workflow fit

    Strategic Deliverables

    CPT/PLA Coding Strategy

    Navigate coding pathways to establish reimbursement identity and accelerate payer onboarding.

    Regulatory-Payer Sequencing

    Align FDA submission timing with coverage decisions to compress the commercialization window.

    03

    Adoption Infrastructure

    Install execution systems that sustain adoption velocity from pilot placement through national distribution.

    Focus Areas

    • ROI Modeling for provider and payer stakeholder defense
    • Pitch Optimization with evidence-based value narratives
    • Early Revenue Execution for repeatable, contracted adoption cycles

    Strategic Deliverables

    Physician Workflow Integration

    Map adoption triggers to clinical workflow to reduce ordering friction and sustain utilization.

    Commercial Readiness Scorecards

    Structured assessment of launch infrastructure across sales, operations, and channel readiness.

    Focused Exclusively on Diagnostic Commercialization

    AdvisoryDx operates in a single vertical. Every engagement, framework, and deliverable is purpose built for the regulatory, reimbursement, and commercial dynamics of the in vitro diagnostics market.

    Deliverables

    Commercial Architecture Deliverables

    Each engagement produces a tailored set of deliverables designed for your stage, market, and regulatory position.

    Market Entry Strategy

    Define care-setting priorities, buyer pathways, and launch sequencing for initial market penetration.

    Pricing Optimization Model

    Structure pricing logic anchored to clinical utility and workflow economics, not competitor benchmarks.

    Product Launch Blueprint

    Operationalize the full launch sequence from regulatory clearance to first contracted adoption.

    National Distribution Roadmap

    Map distributor selection, margin architecture, and channel expansion for scalable national coverage.

    Competitive Positioning Brief

    Articulate defensible positioning against incumbents and adjacent market entrants.

    Sales Enablement Program

    Equip field teams with evidence-based tools, ROI frameworks, and objection handling for complex sales cycles.

    Case Studies

    Where the Architecture Leads

    Case Study

    Molecular Platform Commercialization

    Translated regulatory progress into adoption momentum by sequencing evidence milestones, building clinical utility positioning for formulary discussions, and installing revenue infrastructure before national expansion.

    Read the Full Case Study

    Case Study

    Decentralized Testing Market Launch

    Scaled decentralized testing adoption by identifying early sites with the strongest workflow fit, engineering go-to-market sequencing for rapid first contracts, and deploying sales infrastructure that sustained post-launch velocity.

    Read the Full Case Study

    Methodology

    The AdvisoryDx Methodology: A 6-Layer Decision Architecture

    Every engagement is sequenced through six interdependent decision layers. This architecture replaces ad-hoc consulting with a structured commercialization operating system.

    01Market and Category Strategy
    02Evidence and Adoption Strategy
    03Channel and Distribution Architecture
    04Reimbursement and Access Strategy
    05Launch Sequencing and Field Strategy
    06Stakeholder and Investor Alignment

    Engagement Model

    Every Engagement Begins with a Diagnostic Sprint

    Before we build, we assess. The Diagnostic Sprint is a 2 to 4 week structured evaluation of commercialization readiness that identifies architecture gaps, sequences priorities, and produces the architecture brief that scopes the full engagement.

    2 to 4 weeks

    Diagnostic Sprint

    Diagnose commercialization risk and issue a prioritized architecture brief.

    Key Vectors

    • Assess revenue sequencing readiness across channels
    • Sequence regulatory priorities by commercial impact
    • Map clinical utility gaps before scale commitments

    Flat fee engagement, scoped before kickoff.

    6 to 12 weeks

    Architecture Build

    Build full commercialization architecture for launch readiness and disciplined execution.

    Key Vectors

    • Design operating model across strategy and infrastructure
    • Build launch plan aligned to decentralized testing expansion
    • Install governance cadence for commercial decision control

    Milestone fee schedule tied to delivery gates.

    Quarterly

    Ongoing Advisory

    Direct access to 25 years of IVD leadership and 12 years of early stage diagnostic scaling.

    Key Vectors

    • Guide board level decisions with execution data
    • Adjust sequencing based on channel performance signals
    • Reinforce team accountability against growth objectives

    Monthly retainer, limited annual capacity.

    Not Sure Which Pillar You Need First?

    Most engagements start with a conversation about where you are stuck.

    No pitch. Just a clear recommendation on where to begin.